Christopher Bohach, DPM
Foot Surgery · Willard, OHNPI 1043232341
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by Amgen at 24.5% of the total.
Across 54 payments — averaging $22.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$295
- Paratek Pharmaceuticals, Inc.$224
- Mimedx Group, Inc.$213
- Johnson & Johnson$189
- Stryker$86
- Bioventus LLC$77
- plus $124 from 5 others
What the payments were for
- Food & beverage$1,208100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $295 |
| Paratek Pharmaceuticals, Inc. | 15 | $224 |
| Mimedx Group, Inc. | 12 | $213 |
| Johnson & Johnson | 3 | $189 |
| Stryker | 2 | $86 |
| Bioventus LLC | 1 | $77 |
| Organogenesis Inc. | 3 | $40 |
| Nabriva Therapeutics, PLC | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NA$250
- KRYSTEXXA$125
- HAMMERLOCK$125
- VA-LCP$125
How this compares
$1,208 in reported general payments places this provider in the 65th percentile of 28 foot surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 22 | $1,076 |
| Colchicine | 11 | $884 |
| Gabapentin | 102 | $647 |
| Allopurinol | 87 | $590 |
| Ciclopirox | 24 | $587 |
| Pentoxifylline | 26 | $438 |
| Pregabalin | 21 | $288 |
| Gentamicin Sulfate | 15 | $274 |
| Doxycycline Hyclate | 14 | $171 |
| Terbinafine Hcl | 18 | $160 |
| Duloxetine Hcl | 12 | $114 |
| Cephalexin | 38 | $103 |
| Triamcinolone Acetonide | 12 | $95 |
| Fluconazole | 12 | $75 |
| Tramadol Hcl | 14 | $8 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Willard
- Maggi SmithToledo$12K
- Trenton LeoMansfield$10K
- Georgeanne BotekCleveland$9K
- Richard KunigFairlawn$6K
- Gina HildStrongsville$3K
- John FetzerAkron$3K
- Darrell BallingerCenterville$2K
- Priyanka MudeNorth Canton$2K
- Frank VargoMedina$2K
- Caren AramouniCuyahoga Falls$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.